Cellseed Inc.

Cellseed Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY55.75
Market Cap
JPY12.01 B
Shares Outstanding
11.43 M
Public Float
10.35 M

Profile

Address
Telecom Center Building, 15/F
Tokyo Tokyo 135
Japan
Employees -
Website http://www.cellseed.com
Updated 09/14/2018
CellSeed Inc. develops regenerative medicine products. Its operations are carried out through the following business divisions: Cell Sheet Regenerative Medicine and Intelligent Cell Culture Ware Products. The Cell Sheet Regenerative Medicine division provides research, development, marketing, and sale of epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.

Financials

View All

Setsuko Hashimoto
President, CEO & Representative Director
Jun Onodera
CFO, Director & Manager-Corporate Planning